Literature DB >> 32790187

Occupational dermatology in the time of the COVID-19 pandemic: a report of experience from London and Manchester, UK.

F J Ferguson1, G Street2, L Cunningham1, I R White1, J P McFadden1, J Williams2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32790187      PMCID: PMC7436592          DOI: 10.1111/bjd.19482

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   11.113


× No keyword cloud information.
Dear Editor, The COVID‐19 pandemic has resulted in healthcare systems responding to rapidly rising demand. Simultaneously, increased infection prevention measures for staff, which includes additional personal protective equipment (PPE) and more rigorous hand hygiene procedures, has resulted in an increased incidence of occupational skin disease in frontline staff. From April to June 2020, self‐referral occupational dermatology ‘drop‐in’ and virtual clinics were established at Guy’s and St Thomas’ NHS Foundation Trust (GSTT) and Salford Royal NHS Foundation Trust (SRFT) to support frontline staff. We describe our patient cohorts, delineate the commonly seen diagnoses and offer practical management advice. Questionnaires were completed for each consultation, with 167 consultations (146 staff, average age 35·7 years, range 23–69) at GSTT and 92 (85 staff; average age 39·5 years, range 24–59) at SRFT. Overwhelmingly, staff were female (85·1% at GSTT, 87% SRFT), reflecting the workforce demographic (Table 1).
Table 1

Comparative occupation and job role location data for Guy’s and St Thomas’ (GSTT) and Salford Royal (SRFT) NHS Foundation Trusts, obtained by questionnaire at the time of consultation. The diagnoses at initial consultation were made by the consultant dermatologist in occupational clinics. Some staff were diagnosed with more than one pathology at presentation, with the most significant recorded under primary diagnosis

GSTTSRFT
Staff occupation
Administrative6 (4·1)7 (8)
Allied health professional16 (11·0)23 (27)
Doctor10 (6·8)2 (2)
Healthcare assistant6 (4·1)11 (13)
Nurse105 (71·9)38 (45)
Pharmacist1 (0·7)1 (1)
Support (porter/cleaner)1 (0·7)1 (1)
Other1 (0·7)2 (2)
Total146 (100)85 (100)
Job location
Community1 (0·7)1 (1)
Emergency department1 (0·7)6 (7)
General ward24 (16·4)38 (45)
Intensive care101 (69·2)12 (14)
Surgery9 (6·2)9 (11)
Other8 (5·5)19 (22)
Unknown2 (1·7)0
Total146 (100)85 (100)
DiagnosisPrimarySecondaryPrimarySecondary
Facial dermatoses
Atopic eczema123
Chemical ICD103
Occlusive acne1655
Pressure mechanical ICD41132
Pressure urticaria2
Rosacea14
Seborrhoeic dermatitis565
Suspected ACD8311
Other153
Total8238 (46)251 (4)
Hand dermatoses
Atopic dermatitis49143
ICD5610377
Psoriasis112
Suspected ACD74118
Not occupational4
Total6824 (35)5828 (48)

The data are presented as the number of staff (%). ACD, allergic contact dermatitis; ICD, irritant contact dermatitis.

Comparative occupation and job role location data for Guy’s and St Thomas’ (GSTT) and Salford Royal (SRFT) NHS Foundation Trusts, obtained by questionnaire at the time of consultation. The diagnoses at initial consultation were made by the consultant dermatologist in occupational clinics. Some staff were diagnosed with more than one pathology at presentation, with the most significant recorded under primary diagnosis The data are presented as the number of staff (%). ACD, allergic contact dermatitis; ICD, irritant contact dermatitis. Occupational hand dermatitis is well recognized in healthcare workers. Lan et al. reported occurrence in 74·5% of 526 staff in Hubei province, China. Irritant contact dermatitis (ICD) was present in 97·1% of staff with hand dermatitis at GSTT and 76% at SRFT, reinforcing the importance of preventative strategies for frontline workers. Within our trusts an information leaflet was publicized in trust briefings and on intranets. Moisturizers were made freely available to all staff. This is particularly important as soap substitutes may not offer sufficient virucidal action against COVID‐19· Active dermatitis was treated with topical corticosteroids to gain control and prevent staff absence. With pharmacy assistance, medications were dispensed directly from clinics (GSTT) and prescription fees were waived for occupational dermatoses, facilitating prompt management. Limited patch testing was performed at GSTT (COVID‐19 restrictions) but was carried out according to the European Society of Contact Dermatitis guidelines. Of 12 staff tested with hand dermatitis, five had contact allergies of possible or probable relevance and one had occupational ACD to rubber accelerators in polyisoprene gloves. The high number of clinically relevant results underlines the necessity of patch testing, as highlighted by Cronin. High rates of facial dermatitis from facial masks and/or goggles have been described. This is the first time such significant and frequent issues from medical‐grade, fit‐tested face masks have been observed. Short‐lived erythema (lasting several hours after doffing of PPE) and more significant skin disease were reported (Table 1). Pressure‐induced facial dermatitis has been rarely reported. Pilots in the Royal Air Force, required to wear rubber masks while flying, developed ICD due to pressure, occlusion, heat and friction effects. At GSTT, 66·3% of staff with facial rashes experienced pressure ICD, likely due to both the pressure required to make the FFP3 mask ‘fit’ (i.e. protect against inhalation of airborne virus) and the long periods over which the masks are worn, often in a warm environment. NHS England published advice stating ‘it is important that you take regular breaks (we recommend every two hours) from wearing a mask to relieve the pressure and reduce moisture build‐up.’ In our experience, staff numbers were insufficient to allow this advice to be followed. Our management method is to recommend (i) adherence to the NHS England guidelines; (ii) application of a light moisturizer before shifts and (iii) application of Siltape (Advancis, Kirkby‐in‐Ashfield, UK; soft silicone perforated tape) over the bridge of the nose and cheeks before donning FFP3 masks. If skin breakdown has occurred, Mepilex Border Lite 4 × 5‐cm dressing (Molnlycke, Gothenburg, Sweden) over the bridge of the nose is helpful. These silicone‐based dressings offer both pressure distribution and protection. Additionally, the adhesive minimizes skin damage upon removal. Fit testing should be repeated. The tapes should be removed at each doffing as they may be contaminated. Adhesive remover, such as Appeel wipes (CliniMed Ltd, High Wycombe, UK), may be useful. This methodology has been approved by Infection Control and Tissue Viability. ACD to components of masks has been reported in this pandemic,, but no cases were found in our cohort, although six of 15 staff tested to date had potentially relevant contact allergies. Chemical ICD was seen at GSTT following introduction of reusable masks, with advice to sanitize using Clinell wipes (GAMA Healthcare, Watford, UK) then leave to dry. Build‐up of antimicrobial agents, including benzalkonium chloride, a nonvolatile surfactant known to be an irritant, led to eczema at contact points from the masks. Rinsing with tap water (approved by Infection Control) after use of Clinell wipes resulted in resolution. Staff should wear gloves when handling such wipes. Occupational dermatoses have been the epidemic within the COVID‐19 pandemic. Robust risk assessment and appropriate preventative strategies need to be implemented within the National Health Service. Staff occupational dermatology clinics appear effective in ensuring the wellbeing of frontline staff as we move forward in the ‘new normal’.

Author Contribution

Felicity Jane Ferguson: Conceptualization (lead); Data curation (equal); Formal analysis (lead); Writing‐original draft (lead). Gill Street: Data curation (equal). Louise Sarah Cunningham: Writing‐review & editing (equal). Ian R White: Supervision (supporting); Writing‐review & editing (equal). John McFadden: Conceptualization (supporting); Writing‐review & editing (equal). Jason Williams: Conceptualization (supporting); Writing‐review & editing (equal).
  8 in total

1.  Irritant dermatitis due to prolonged contact with Oilatum Plus.

Authors:  W J Loo
Journal:  Br J Dermatol       Date:  2003-01       Impact factor: 9.302

2.  European Society of Contact Dermatitis guideline for diagnostic patch testing - recommendations on best practice.

Authors:  Jeanne D Johansen; Kristiina Aalto-Korte; Tove Agner; Klaus E Andersen; Andreas Bircher; Magnus Bruze; Alicia Cannavó; Ana Giménez-Arnau; Margarida Gonçalo; An Goossens; Swen M John; Carola Lidén; Magnus Lindberg; Vera Mahler; Mihály Matura; Thomas Rustemeyer; Jørgen Serup; Radoslaw Spiewak; Jacob P Thyssen; Martine Vigan; Ian R White; Mark Wilkinson; Wolfgang Uter
Journal:  Contact Dermatitis       Date:  2015-07-14       Impact factor: 6.600

3.  Clinical prediction of patch test results.

Authors:  E Cronin
Journal:  Trans St Johns Hosp Dermatol Soc       Date:  1972

Review 4.  Dermatitis caused by physical irritants.

Authors:  R Morris-Jones; S J Robertson; J S Ross; I R White; J P McFadden; R J G Rycroft
Journal:  Br J Dermatol       Date:  2002-08       Impact factor: 9.302

Review 5.  Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents.

Authors:  G Kampf; D Todt; S Pfaender; E Steinmann
Journal:  J Hosp Infect       Date:  2020-02-06       Impact factor: 3.926

6.  Allergic contact dermatitis caused by elastic bands from FFP2 mask.

Authors:  Francisco J Navarro-Triviño; Carolina Merida-Fernández; Teresa Ródenas-Herranz; Ricardo Ruiz-Villaverde
Journal:  Contact Dermatitis       Date:  2020-06-01       Impact factor: 6.600

7.  Skin damage among health care workers managing coronavirus disease-2019.

Authors:  Jiajia Lan; Zexing Song; Xiaoping Miao; Hang Li; Yan Li; Liyun Dong; Jing Yang; Xiangjie An; Yamin Zhang; Liu Yang; Nuoya Zhou; Liu Yang; Jun Li; JingJiang Cao; Jianxiu Wang; Juan Tao
Journal:  J Am Acad Dermatol       Date:  2020-03-18       Impact factor: 11.527

8.  Mask-induced contact dermatitis in handling COVID-19 outbreak.

Authors:  Zhen Xie; Yu-Xin Yang; Hao Zhang
Journal:  Contact Dermatitis       Date:  2020-05-26       Impact factor: 6.600

  8 in total
  7 in total

1.  Comparing the quantitative fit-testing results of half-mask respirators with various skin barriers in a crossover study design: a pilot study.

Authors:  R S Trehan; E P McDonnell; J V McCoy; P A Ohman-Strickland; C Donovan; T R Quinoa; D S Morrison
Journal:  J Hosp Infect       Date:  2021-02-15       Impact factor: 3.926

2.  Physical and psychological impacts of handwashing and personal protective equipment usage in the COVID-19 pandemic: A UK based cross-sectional analysis of healthcare workers.

Authors:  Emily S Burns; Pirunthan Pathmarajah; Vijaytha Muralidharan
Journal:  Dermatol Ther       Date:  2021-03-06       Impact factor: 3.858

Review 3.  Personal protective equipment-related occupational dermatoses during COVID-19 among health care workers: A worldwide systematic review.

Authors:  Bryan M H Keng; Wee Hoe Gan; Yew Chong Tam; Choon Chiat Oh
Journal:  JAAD Int       Date:  2021-09-01

Review 4.  Physical problems of prolonged use of personal protective equipment during the COVID-19 pandemic: A scoping review.

Authors:  Arpi Manookian; Nahid Dehghan Nayeri; Mehraban Shahmari
Journal:  Nurs Forum       Date:  2022-05-16

5.  Adverse skin reactions among health care workers using face personal protective equipment during the coronavirus disease 2019 pandemic: A cross-sectional survey of six hospitals in Denmark.

Authors:  Jette G Skiveren; Malene F Ryborg; Britt Nilausen; Susan Bermark; Peter A Philipsen
Journal:  Contact Dermatitis       Date:  2021-12-27       Impact factor: 6.419

6.  Symptoms Associated With Personal Protective Equipment Among Frontline Health Care Professionals During the COVID-19 Pandemic.

Authors:  Ahmet Çağlar; İlker Kaçer; Muhammet Hacımustafaoğlu; Berkant Öztürk; Kemal Öztürk
Journal:  Disaster Med Public Health Prep       Date:  2020-11-19       Impact factor: 1.385

7.  Occupational dermatoses during the second wave of the COVID-19 pandemic: a UK prospective study of 805 healthcare workers.

Authors:  J M Gao; R Goiriz; S Rajpopat; P Goldsmith
Journal:  Br J Dermatol       Date:  2021-11-15       Impact factor: 11.113

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.